ADRIBLASTINA

This brand name is authorized in Brazil, Cyprus, Estonia, Mexico, Poland, South Africa

Active ingredients

The drug ADRIBLASTINA contains one active pharmaceutical ingredient (API):

1 Doxorubicin UNII 82F2G7BL4E - DOXORUBICIN HYDROCHLORIDE

Doxorubicin is a cytotoxic anthracycline antibiotic obtained from Streptomyces peucetius var. caesius. The exact mechanism of the antitumour activity of doxorubicin is not known. It is generally believed that inhibition of DNA, RNA and protein synthesis is responsible for the majority of the cytotoxic effects. Read about Doxorubicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01DB01	Doxorubicin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522718030075117, 522718030075217
Country: EE	Ravimiamet	Identifier(s): 1043064, 1069736, 1793280
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 205M89
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100092424
Country: ZA	Health Products Regulatory Authority	Identifier(s): 33/26/0102, 33/26/0104, F/26/274, F/26/289, U/26/183